Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future

A A Roger Thompson^{1

2}, Martin R Wilkins³, Jim M Wild^{1

4

5}, David G Kiely^{1

2

5}, Allan Lawrie^{1

5}

Affiliations

¹ Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
² Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
³ Department of Medicine and National Heart and Lung Institute, Imperial College London, London, United Kingdom.
⁴ POLARIS, Academic Unit of Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁵ INSIGNEO Institute for in silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

Editorial

A A Roger Thompson et al. Front Med (Lausanne). 2020.

. 2020 Apr 21:7:125.

doi: 10.3389/fmed.2020.00125. eCollection 2020.

A A Roger Thompson^{1

2}, Martin R Wilkins³, Jim M Wild^{1

4

5}, David G Kiely^{1

2

5}, Allan Lawrie^{1

5}

¹ Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
² Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
³ Department of Medicine and National Heart and Lung Institute, Imperial College London, London, United Kingdom.
⁴ POLARIS, Academic Unit of Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁵ INSIGNEO Institute for in silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

No abstract available

Keywords: biomarkers; heart failure; imaging; pulmonary hypertension; screening tools; therapeutics.

Comment on

Editorial on the Research Topic Pulmonary Hypertension: Mechanisms and Management, History and Future

1. Heath D. Travellers on a Hidden River. J Med Biogr. (1998) 6:105–113. 10.1177/096777209800600208 - DOI - PubMed
1. Heath D, Whitaker W. Hypertensive pulmonary vascular disease. Circulation. (1956) 14:323–43. 10.1161/circ.14.3.323 - DOI - PubMed
1. Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, et al. The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J. (2018) 52:1800589. 10.1183/13993003.00589-2018 - DOI - PMC - PubMed
1. National Audit of Pulmonary Project Board National Audit of Pulmonary Hypertension, 10th Annual Report - NHS Digital. (2019). Available online at: https://digital.nhs.uk/data-and-information/publications/statistical/nat... (accessed November 24, 2019).
1. Bergemann R, Allsopp J, Jenner H, Drage E, Samyshkin Y, Schmitt C, et al. High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project. Pulm Circ. (2018) 8:1–9. 10.1177/2045894018798613 - DOI - PMC - PubMed